Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Meiss

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Cancer Research : MCR|November 12, 2009
Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cellsGeraldine Gueron, Adriana De Siervi, Mercedes Ferrando, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|July 30, 2016
Pleiotropic effects of 5-aminolevulinic acid in mouse brainJimena Lavandera, Jorge Rodríguez, Silvina Ruspini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell numberGabriela Lombardi, Dalia Burzyn, Juliana Mundiñano, et al.
Innate Immunity|September 20, 2013
Dehydroepiandrosterone and metyrapone partially restore the adaptive humoral and cellular immune response in endotoxin immunosuppressed miceBárbara Rearte, Andrea Maglioco, Damián Machuca, et al.
Oncology Letters|May 20, 2017
B cells inhibit the antitumor immunity against an established murine fibrosarcomaAndrea Maglioco, Damián G Machuca, María Noel Badano, et al.
Infection and Immunity|July 9, 2014
Retinoid levels influence enterohemorrhagic Escherichia coli infection and Shiga toxin 2 susceptibility in miceGabriel Cabrera, Romina J Fernández-Brando, María Jimena Abrey-Recalde, et al.
Current Pharmaceutical Biotechnology|November 9, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate CancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Current Pharmaceutical Biotechnology|April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Neoplasia (New York, N.Y.)|December 11, 2012
Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradationBelen Elguero, Geraldine Gueron, Jimena Giudice, et al.
Infection and Immunity|December 22, 2010
Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsisGabriela Barrera, Verónica Landoni, Daiana Martire-Greco, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Cancer Research : MCR|November 12, 2009
Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cellsGeraldine Gueron, Adriana De Siervi, Mercedes Ferrando, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|July 30, 2016
Pleiotropic effects of 5-aminolevulinic acid in mouse brainJimena Lavandera, Jorge Rodríguez, Silvina Ruspini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell numberGabriela Lombardi, Dalia Burzyn, Juliana Mundiñano, et al.
Innate Immunity|September 20, 2013
Dehydroepiandrosterone and metyrapone partially restore the adaptive humoral and cellular immune response in endotoxin immunosuppressed miceBárbara Rearte, Andrea Maglioco, Damián Machuca, et al.
Oncology Letters|May 20, 2017
B cells inhibit the antitumor immunity against an established murine fibrosarcomaAndrea Maglioco, Damián G Machuca, María Noel Badano, et al.
Infection and Immunity|July 9, 2014
Retinoid levels influence enterohemorrhagic Escherichia coli infection and Shiga toxin 2 susceptibility in miceGabriel Cabrera, Romina J Fernández-Brando, María Jimena Abrey-Recalde, et al.
Current Pharmaceutical Biotechnology|November 9, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate CancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Current Pharmaceutical Biotechnology|April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Neoplasia (New York, N.Y.)|December 11, 2012
Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradationBelen Elguero, Geraldine Gueron, Jimena Giudice, et al.
Infection and Immunity|December 22, 2010
Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsisGabriela Barrera, Verónica Landoni, Daiana Martire-Greco, et al.
Pageof 3